Physician profile
Joseph Lipscomb
NPI 1154426187
$2,876.19
in general payments reported to CMS, 2019-2025
19 companies · $525 in 2025
The $525 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $203 · 2021: $511 · 2022: $717 · 2023: $386 · 2024: $234 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $491.46 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $430.42 | 2019-2024 | Jornay Pm |
| Tris Pharma INC | $427.19 | 2019-2025 | Onyda Xr, Dyanavel Xr |
| Gm Pharmaceuticals, INC. | $391.59 | 2022 | |
| Glaxosmithkline, LLC. | $377.86 | 2019-2025 | Bexsero |
| Supernus Pharmaceuticals, INC. | $197.37 | 2021-2025 | Qelbree, Qelbree |
| Collegium Pharmaceutical, INC. | $134.79 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $83.02 | 2020-2022 | |
| Cranial Technologies, INC | $68.39 | 2021-2023 | Doc Band |
| Sanofi Pasteur INC. | $57.17 | 2020-2025 | |
| Neos Therapeutics, LP | $38.05 | 2021 | |
| Merck Sharp & Dohme LLC | $36.02 | 2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Genentech USA, INC. | $35.28 | 2020-2021 | |
| Organon LLC | $26.15 | 2023 | Nexplanon |
| Adlon Therapeutics L.P. | $18.80 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $17.61 | 2025 | Xelstrym |
| Pfizer INC. | $15.74 | 2024 | |
| Vertical Pharmaceuticals, LLC | $15.33 | 2019 | |
| Shire North American Group INC | $13.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Lipscomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.